<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02470377</url>
  </required_header>
  <id_info>
    <org_study_id>2012-003-01</org_study_id>
    <nct_id>NCT02470377</nct_id>
  </id_info>
  <brief_title>Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome</brief_title>
  <official_title>Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laureate Institute for Brain Research, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laureate Institute for Brain Research, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to determine whether external neuromodulation using repetitive
      transcranial magnetic stimulation (rTMS) can reduce the perception of self-motion that is
      experienced by individuals with mal de debarquement syndrome (MdDS). Mal de debarquement is
      translated as the &quot;sickness of disembarkment,&quot; and refers to the chronic feeling of rocking
      dizziness that occurs after exposure to passive motion. Treatment for MdDS is limited and
      morbidity is high. The goal of the study is to determine whether rTMS can suppress the
      rocking dizziness of MdDS and to determine whether imaging and electrical biomarkers can aide
      in more effective targeting. The investigators will make correlations between functional
      magnetic resonance imaging (fMRI), electroencephalography (EEG), and specific clinical
      features to determine whether functional connectivity between particular hubs in the brain
      correlate with clinical improvement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will maintain web-based diaries of their symptoms for two weeks prior to
      treatment with rTMS. Up to 20 treatments with rTMS with either anatomically or functionally
      determined targets will be administered. Treatments will be preceded by an fMRI scan and EEG
      recording prior to the first rTMS treatment and will be followed by an fMRI and EEG after the
      last treatment. Post treatment diaries will continue for up to 12 weeks after rTMS
      administration.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dizziness Handicap Inventory</measure>
    <time_frame>10 years</time_frame>
    <description>This is a well validated 100 point self-reported scale with Functional, Physical, and Emotional components.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mal de Debarquement Balance Rating Scale</measure>
    <time_frame>10 years</time_frame>
    <description>This is a 10 point self-reported scale that assesses the severity of rocking dizziness and its effect on balance function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale</measure>
    <time_frame>10 years</time_frame>
    <description>This is a well validated 42 point self-reported scale of anxiety and dizziness.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>SF-12</measure>
    <time_frame>10 years</time_frame>
    <description>Well-established Quality of Life Scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Motion Sickness Susceptibility Scale</measure>
    <time_frame>10 years</time_frame>
    <description>Measures motion sickness susceptibility before and after age 12</description>
  </other_outcome>
  <other_outcome>
    <measure>Neo-Five Factor Inventory</measure>
    <time_frame>10 years</time_frame>
    <description>Quantifies the five major personality traits</description>
  </other_outcome>
  <other_outcome>
    <measure>Empathy Quotient</measure>
    <time_frame>10 years</time_frame>
    <description>40-item online or 20-item abbreviated scale to determine strength of empathic traits</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional Activities Scale</measure>
    <time_frame>10 years</time_frame>
    <description>Measures comfort with doing some basic activities of daily living</description>
  </other_outcome>
  <other_outcome>
    <measure>Memory Questionnaire</measure>
    <time_frame>10 years</time_frame>
    <description>Measures subjective impressions of prospective and retrospective memory</description>
  </other_outcome>
  <other_outcome>
    <measure>Multidimensional Fatigue Inventory</measure>
    <time_frame>10 years</time_frame>
    <description>Measures general, physical, and mental fatigue</description>
  </other_outcome>
  <other_outcome>
    <measure>Edinburgh Handedness Scale</measure>
    <time_frame>10 years</time_frame>
    <description>Standard measure of handedness</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Mal de Debarquement Syndrome</condition>
  <arm_group>
    <arm_group_label>Transcranial Magnetic Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After determination of the motor threshold, the TMS coil will be positioned at predetermined locations over the brain using MRI guidance and a frameless stereotaxy system. A train of stimulation pulses (repetitive TMS) at 1Hz up to 10Hz or in theta burst mode will be delivered at one or more locations over the head, depending on the brain location under study (brain locations determined by MRI data). Real or active sham conditions will be used in the study but all participants will receive real treatment at some point during their enrollment. Real rTMS over one area may also be compared to real rTMS over another area.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation</intervention_name>
    <description>A form of external neuromodulation using pulsatile magnetic fields on the surface of the head.</description>
    <arm_group_label>Transcranial Magnetic Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. Age â‰¥18 years old

          2. Willing and capable of interacting with the informed consent process

          3. Primary disorder being a persistent rocking dizziness triggered by passive motion such
             as from water, land, or air travel and with no other central nervous system or
             peripheral vestibular disorder determined after appropriate evaluation.

        Exclusion criteria:

          1. Subjects who cannot comply with study conditions.

          2. Active psychiatric condition such as mania or psychosis

          3. Unstable medical condition

          4. Implanted metal anywhere in the body (infusion pumps, pacemakers, metal or shrapnel in
             the body, deep brain stimulators, aneurysm clips, metal prostheses, joints, rods or
             plates). Dental fillings are acceptable.

          5. Personal history of seizures or a first-degree relative with epilepsy

          6. Medications known to lower seizure threshold such as: typical (high-potency)
             neuroleptics and tricyclic antidepressants: Subjects who take one or a combination of
             the following drugs will be excluded: imipramine, amitriptyline, doxepin,
             nortriptyline, maprotiline, chlorpromazine. clozapine, foscarnet, ganciclovir,
             ritonavir, amphetamines, cocaine (including MDMA, ecstasy), phencyclidine (PCP,
             angel's dust), ketamine, gamma-hydroxybutyrate (GHB), theophylline, haloperidol,
             fluphenazine, bupropion.

          7. Pregnancy or planning to become pregnant during study enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoon-Hee Cha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laureate Institute for Brain Resarch</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diamond Urbano, BA</last_name>
    <phone>918-502-5127</phone>
    <email>mddsresearch@laureateinstitute.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yoon-Hee Cha, MD</last_name>
    <phone>918-502-5122</phone>
    <email>ycha@laureateinstitute.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Laureate Institute for Brain Research</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diamond Urbano, BA</last_name>
      <phone>918-502-5126</phone>
      <email>mddsresearch@laureateinstitute.org</email>
    </contact>
    <investigator>
      <last_name>Yoon-Hee Cha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cha YH. Mal de debarquement syndrome: new insights. Ann N Y Acad Sci. 2015 Apr;1343:63-8. doi: 10.1111/nyas.12701. Epub 2015 Feb 27.</citation>
    <PMID>25726862</PMID>
  </reference>
  <reference>
    <citation>Ding L, Shou G, Yuan H, Urbano D, Cha YH. Lasting modulation effects of rTMS on neural activity and connectivity as revealed by resting-state EEG. IEEE Trans Biomed Eng. 2014 Jul;61(7):2070-80. doi: 10.1109/TBME.2014.2313575. Epub 2014 Mar 25.</citation>
    <PMID>24686227</PMID>
  </reference>
  <reference>
    <citation>Cha YH, Cui Y, Baloh RW. Repetitive transcranial magnetic stimulation for mal de debarquement syndrome. Otol Neurotol. 2013 Jan;34(1):175-9. doi: 10.1097/MAO.0b013e318278bf7c.</citation>
    <PMID>23202153</PMID>
  </reference>
  <reference>
    <citation>Cha YH, Chakrapani S, Craig A, Baloh RW. Metabolic and functional connectivity changes in mal de debarquement syndrome. PLoS One. 2012;7(11):e49560. doi: 10.1371/journal.pone.0049560. Epub 2012 Nov 29.</citation>
    <PMID>23209584</PMID>
  </reference>
  <reference>
    <citation>Guofa Shou, Han Yuan, Urbano D, Yoon-Hee Cha, Lei Ding. Changes of symptom and EEG in mal de debarquement syndrome patients after repetitive transcranial magnetic stimulation over bilateral prefrontal cortex: a pilot study. Conf Proc IEEE Eng Med Biol Soc. 2014;2014:4294-7. doi: 10.1109/EMBC.2014.6944574.</citation>
    <PMID>25570942</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2015</study_first_submitted>
  <study_first_submitted_qc>June 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2015</study_first_posted>
  <last_update_submitted>March 6, 2017</last_update_submitted>
  <last_update_submitted_qc>March 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laureate Institute for Brain Research, Inc.</investigator_affiliation>
    <investigator_full_name>Yoon-Hee Cha</investigator_full_name>
    <investigator_title>Yoon-Hee Cha, MD</investigator_title>
  </responsible_party>
  <keyword>MdDS</keyword>
  <keyword>TMS</keyword>
  <keyword>fMRI</keyword>
  <keyword>EEG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Motion Sickness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Anonymized data may be shared with other researchers when there is sufficient recruitment to assure that no individual may be identified based on demographic or clinical characteristics.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

